Evidence map›Paper›PMID 26950123›Full record

ReviewInternational journal of molecular sciences2016

Biomaterials with Antibacterial and Osteoinductive Properties to Repair Infected Bone Defects.

Haiping Lu, Yi Liu, Jing Guo, Huiling Wu, Jingxiao Wang, Gang Wu

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Haiping LuSchool of Stomatology, Zhejiang Chinese Medical University, Hangzhou 310053, China. noprint2000@hotmail.com.
Yi LiuDepartment of Oral Implantology and Prosthetic Dentistry, Academic Center for Dentistry Amsterdam (ACTA), University of Amsterdam and VU University Amsterdam, MOVE Research Institute, Amsterdam 1081LA, The Netherlands. liuyizzd@163.com.
Jing GuoSchool of Stomatology, Zhejiang Chinese Medical University, Hangzhou 310053, China. tracyguo1218@hotmail.com.
Huiling WuThe First Affiliated Hospital, Medical School, Zhejiang University, Hangzhou 310003, China. whl1616@126.com.
Jingxiao WangThe First Affiliated Hospital, Wenzhou Medical University, Wenzhou 325000, China. wangjingxiao@zju.edu.cn.
Gang WuDepartment of Oral Implantology and Prosthetic Dentistry, Academic Center for Dentistry Amsterdam (ACTA), University of Amsterdam and VU University Amsterdam, MOVE Research Institute, Amsterdam 1081LA, The Netherlands. g.wu@acta.nl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The repair of infected bone defects is still challenging in the fields of orthopedics, oral implantology and maxillofacial surgery. In these cases, the self-healing capacity of bone tissue can be significantly compromised by the large size of bone defects and the potential/active bacterial activity. Infected bone defects are conventionally treated by a systemic/local administration of antibiotics to control infection and a subsequent implantation of bone grafts, such as autografts and allografts. However, these treatment options are time-consuming and usually yield less optimal efficacy. To approach these problems, novel biomaterials with both antibacterial and osteoinductive properties have been developed. The antibacterial property can be conferred by antibiotics and other novel antibacterial biomaterials, such as silver nanoparticles. Bone morphogenetic proteins are used to functionalize the biomaterials with a potent osteoinductive property. By manipulating the carrying modes and release kinetics, these biomaterials are optimized to maximize their antibacterial and osteoinductive functions with minimized cytotoxicity. The findings, in the past decade, have shown a very promising application potential of the novel biomaterials with the dual functions in treating infected bone defects. In this review, we will summarize the current knowledge of novel biomaterials with both antibacterial and osteoinductive properties.

Indexed as

AnimalsAnti-Bacterial AgentsBacterial InfectionsBiocompatible MaterialsBone and BonesBone Morphogenetic ProteinsBone RegenerationDrug Delivery SystemsHumansOsteogenesisWound HealingAnti-Bacterial AgentsBiocompatible MaterialsBone Morphogenetic Proteinsantibacterialantibioticsbone morphogenetic protein2 (BMP2)bone regenerationco-deliveryinfected bone defectosteoinductive

Identifiers

PMID26950123
PMCPMC4813196

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.